ArticleEuropean heart journal open2026
Risk prediction of death and heart transplantation in adult patients with myocarditis.
Article in European heart journal open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Identifying early risk predictors in myocarditis is clinically relevant, as patients' outcomes may be very diverse. We aimed to explore predictors of death and heart transplant (HTx) in a large single-centre cohort of adult patients with myocarditis using a machine learning (ML) technique. Methods and results: We retrospectively enrolled consecutive adult patients with biopsy-proven or clinically suspected myocarditis, collecting clinical, laboratory, and imaging data, both at diagnosis and during follow-up. A predictive model of death/HTx was developed using random forest (RF), ranking covariates according to their predictive accuracy. We included 938 patients (median age 36 years, 69% male) with clinically suspected ( Conclusion: Based on a ML approach, we found, with good predictive accuracy, that advanced NYHA class, reduced LVEF and heart failure at diagnosis, and giant cell myocarditis on EMB are predictors of worse prognosis in adult patients with myocarditis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.